These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7941537)

  • 21. [Does the cyclic treatment with ovulation inhibitors produce pseudopregnancy?].
    Siegel P
    Gynaecologia; 1966; 161(2):151-4. PubMed ID: 5925685
    [No Abstract]   [Full Text] [Related]  

  • 22. [Megestrol acetate in gynecological therapy].
    Dumont M; Moine C; Jacquot D; Dubois P
    Rev Fr Gynecol Obstet; 1966 Dec; 61(12):909-18. PubMed ID: 5986674
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of the structure of steroids on their antiovulatory, antigonadotropic, and progestative activity].
    Jayle MF
    Therapie; 1968; 23(2):201-21. PubMed ID: 5701506
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical studies with synthetic gestagens].
    Tóth F; Horn B; Primász P
    Orv Hetil; 1969 Jul; 110(30):1723-7. PubMed ID: 5801101
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ovulation-inhibiting tablets in diabetics].
    Poulsen JE
    Nord Med; 1966 Jan; 75(3):77-8. PubMed ID: 5903331
    [No Abstract]   [Full Text] [Related]  

  • 26. [Letter: Therapy of vaginal discharge using the "mini pill"].
    Kepp R
    Dtsch Med Wochenschr; 1974 Jul; 99(29):1544. PubMed ID: 4849101
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hormonal contraception].
    Kohoutek M; Fabián M; Kohoutek F
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1968; 11(5):691-5. PubMed ID: 5257733
    [No Abstract]   [Full Text] [Related]  

  • 28. [Functional changes of the corpus luteum induced by gestagens. Possible mechanism of action of various steroids that inhibit fertility].
    Pupkin M; Guerrero R; Rosenberg D; Zañartu J
    Rev Chil Obstet Ginecol; 1970; 35(6):249-53. PubMed ID: 5527775
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute intermittent porphyria and hormones. Treatment with oral contraceptives].
    Rausch-Stroomann JG; Schley G; Hocevar V
    Med Welt; 1970 May; 21():836-45. PubMed ID: 5525897
    [No Abstract]   [Full Text] [Related]  

  • 30. [The ovulation inhibitors in clinical practice].
    Vaglio N
    Minerva Med; 1969 Apr; 60(31):1522-3. PubMed ID: 5783949
    [No Abstract]   [Full Text] [Related]  

  • 31. [Findings in various metabolic sectors in relation to the administration of synthetic estroprogestins].
    Carobi Lauro C; Corea L; Marinelli M; Lauro V; Porcellati C
    Arch Ostet Ginecol; 1969; 74(2):178-90. PubMed ID: 5406258
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral contraceptives and cell replication.
    Beaconsfield P; Ginsburg J
    Lancet; 1968 Mar; 1(7542):592. PubMed ID: 4170292
    [No Abstract]   [Full Text] [Related]  

  • 33. Early experience in contraception with a new progestogen.
    McEwan JA; Joyce DN; Tothill AU; Hawkins DF
    Contraception; 1977 Oct; 16(4):339-50. PubMed ID: 923246
    [No Abstract]   [Full Text] [Related]  

  • 34. Antithrombin III levels in Indian women during pregnancy, post-partum and intake of oral contraceptives.
    Toddywalla VS; Virkar KD
    J Obstet Gynaecol India; 1978 Feb; 28(1):52-4. PubMed ID: 689281
    [No Abstract]   [Full Text] [Related]  

  • 35. Excretion of gonadotrophins during gestagen- and oestrogen-treatment. The excretion of total pituitary gonadotrophins in menopausal and oophorectomized women during treatment with 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone and 17-alpha-ethynyl-oestradiol-3-methylether respectively.
    Starup J
    Acta Endocrinol (Copenh); 1967 Apr; 54(4):637-44. PubMed ID: 6071486
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of an oral progestogen of feedlot heifers.
    Young AW; Cundiff LV; Bradley NW
    J Anim Sci; 1969 Feb; 28(2):224-6. PubMed ID: 5813035
    [No Abstract]   [Full Text] [Related]  

  • 37. [For a better understanding of birth problems: the gynecologist-psychiatrist relation associated with a new therapy].
    Lagroua Weill-Hallé MA
    Sem Hop Ther; 1974; 50(7-8):485-7. PubMed ID: 4614454
    [No Abstract]   [Full Text] [Related]  

  • 38. Estrogen, progestogens and cardiovascular risk.
    Stefanick ML
    J Reprod Med; 1999 Feb; 44(2 Suppl):221-6. PubMed ID: 11392036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Problems of oral contraception with special reference to the development, pharmacodynamics and effectiveness of currently used preparations].
    Richter RH
    Ther Umsch; 1967 Jun; 24(6):218-25. PubMed ID: 5616439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.